It started with black bears. It was 1999, and University of Minnesota researcher Paul Iaizzo connected with Tim Laske, now vice president of research in Medtronic's cardiac ablation products business.

Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...

After receiving the necessary regulatory approval, Medtronic is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance ...

Medtronic's Reveal XT subcutaneous cardiac monitor is now commercially available in the U.S. The company introduced Reveal XT in Europe in July of 2007. The device helps physicians diagnose heart ...

The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient’s chest during a minimally invasive procedure. The implanted device allows clinicians to continuously ...

GAITHERSBURG, Md., March 1 (Reuters) - A U.S. advisory panel on Thursday voted 9-2 against recommending approval of a Medtronic Inc. implantable device that monitors the heart and sends data to ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Parkview Health announced today that its Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to participate in a clinical trial of a new heart ...